China 3415-08-5 L-Tyr-NCA Manufacturer and Factory |Jiayinglai

3415-08-5 L-Tyr-NCA

Tsanangudzo Pfupi

Chitarisiko	Machena kusvika kuOff-White makristasi kana crystalline poda
MF	C10H9NO4
MW	207.18
Kuchena	98+

Tumira email kwatiri

Product Detail

Mamiriro ekufambisa & inokurudzirwa nzira yekutumira:
nemhepo, negungwa kana nekutaura

Mamiriro ekuchengetera:
nert atmosphere,Chengeta mufiriji, pasi -20°C

Minimum Order Qty:
Kukurukurirana

Certification:
COA, HPLC, GC, HNMR, Assay, Mvura Yemukati(KF), TLC iripo

Mashoko anoreva zvakafanana

Tyrosine, NCA;

N-Carboxy-L-tyrosine anhydride;

(4S) -4- [(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl]-, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

Inner Packing

Vanowanzo shandiswa kutakura hupfu.Uye vanogona kudzivirira kupenya kwezuva nemvura kuti zvisashata.

kurongedza kwekunze

Iyo hard carton inogona kuchengetedza zvigadzirwa zvako kubva pakuputsika uye kunyorova.

Applications

3415-08-5 L-Tyr-NCA ndeimwe yepakati peGlatiramer Acetate.

Glatiramer Acetate inhengo yepeptide yakagadzirwa yakagadzirwa ine mana amino acids: glutamic acid, alanine, tyrosine, uye lysine.Chishandiso chayo chekutanga chiri mukurapa kweMultiple Sclerosis (MS), chirwere chisingaperi, chinopisa, chinopedza miyelinating chinokanganisa iyo yepakati tsinga system.Kuburikidza nenzira ye "bypass kudzvinyirira," Glatiramer Acetate inoshandisa immunomodulatory uye anti-inflammatory effects muMS, kuwedzera mazinga europi-derived neurotrophic factor (BDNF), kuderedza kuzvimba-induced demyelination, nekusimudzira kukura kwemaaxon uye myelin sheaths.

Pasi rose, Glatiramer Acetate yakawana kushandiswa kwakapararira.Semuenzaniso, muUnited States, inotengeswa pasi pezita remhando yeCopaxone uye yakabvumidzwa neFood and Drug Administration (FDA) kurapwa kweMultiple Sclerosis.Munyika dzekuMadokero dzine huwandu hwakanyanya hweMS, kushanda kwayo uye kushivirira kwave kuchizivikanwa zvakanyanya.

KuChina, musi waChikumi 28, 2023, "Glatiramer Acetate Injection" yakagamuchirwa zviri pamutemo kubva kuNational Medical Products Administration (NMPA) yekurapa varwere vakura vane kudzoka-remitting Multiple Sclerosis (MS), kusanganisira kiriniki yakasarudzika chirwere, kudzoka-remitting. MS, uye inoshanda yechipiri inofambira mberi MS.

zvinoenderana zvigadzirwa

L-Gly-NCA	L-Ala-NCA	D-Ala-NCA	L-Val-NCA
D-Leu-NCA	DL-leu-NCA	L-Phe-NCA	D-Tyr-NCA
L-Tyr(bzl)-NCA	L-Glu(Obzl)-NCA	D-Asp(OBzl)-NCA	L-Ls(tfa)-NCA
L-Ls(Cbz)-NCA	D-Ls(Cbz)-NCA	Sar-NCA

Superiority

1. R&D sevhisi iripo
2. ISO yakasimbiswa mugadziri, vimbiso yehutano
3.Nzira yakazara yebasa rekutevera panguva yekugadzirwa
4.Kudhura kwakanyanya
5.Quality certification magwaro anopiwa pane chikumbiro chemutengi
6.Great after-sales service, kuchengetedza ukama hwepedyo nemutengi
7.Full resource kubatsira kuderedza mari yekutumira
8.Free sampuli yakapihwa kuti utarise kunaka kusati kwabhadharwa
9.Payment term yakataurirana
10.Assit vatengi vanobata nenyaya muChina